💡 Interested to dive into spatial understanding of the tumor microenvironment for drug discoveries and new anti-cancer therapies?
▶️ Join IMMUNO-model webinar on December 19 at 2 pm CET
More info and registration:
https://t.co/1V1r4J1K4n
#immunomodel#spatialbiology
Don't miss your chance to contribute to the next edition of the EACR-@AstraZeneca conference, bringing the spotlight on ctDNA! Abstract submissions close in one month on 18 November:
https://t.co/OeamW9OIa5
The National Institute of Biology was proud to host Chika Yokota, Head of Unit of the In Situ Sequencing National Facility at Stockholm University/@scilifelab in Sweden and a researcher working on our joint @cut_cancer Project. Glad to have you Chika:)
Let's beat brain cancer together. We are organizing the #COST#Net4Brain annual meeting at NIB. Honored to have great speaker and amazing network to approach #braintumors from different and much needed ways. @CancerBiologyG1@cut_cancer
Very excited to share our work published in @iScience_CP ! Check it out🧫🔬🧬⬅️
Patient-derived tumor organoids mimic treatment-induced DNA damage res... https://t.co/FBq3DrUHG4
@cut_cancer
Very proud to be part of very exciting and much needed #SPACETIME project.
@CancerBiologyG1 group from NIB (National Institute of Biology) lead by Barbara Breznik is ready to start:)
SPACETIME project starts today! 15 partners from 7 different European countries will work on spatially decoding lung cancer 🫁🔬. Today, we honor the World Lung Cancer Day and commit to do our best for patients! #SPACETIME#WorldLungCancerDay#EUfunded#HaDEA#EUMissionCancer🇪🇺
SPACETIME project starts today! 15 partners from 7 different European countries will work on spatially decoding lung cancer 🫁🔬. Today, we honor the World Lung Cancer Day and commit to do our best for patients! #SPACETIME#WorldLungCancerDay#EUfunded#HaDEA#EUMissionCancer🇪🇺
🌎🧠Each year on June 8th, #WorldBrainTumorDay is celebrated to raise awareness, educate about brain tumors, & support those affected by it. EANO is dedicated to foster advances in #NeuroOncology through innovative research, concerted education & training https://t.co/y0X47uT12H
Great @immunomodel conference in Bratislava where we also presented our work on glioblastoma organoid model as a personalized tool for therapy testing. Great networking a lot of new knowledge and fresh energy to continue #cancer research.
@cut_cancer
IMMUNO-model Second Annual Conference: From Pre-clinical Models to the Search for Biomarkers in Immuno-Oncology
#Keynote Lecture by Dr. Víctor Cortés, OneChain Immunotherapeutics, S. L. "Preclinical validation of humanized CAR-Ts cells in the indusry: the bench to the bedside".
We need a little bit of all our diverse knowledge to recognize, understand and treat brain cancer so that one day we can say that we have it under control.
GlioBank, a Slovenian translational platform gather at NIB to plan future research strategies for GB patients. @cut_cancer
We are very grateful and happy to have Maria Escriva Conde, from @MatsNilssonLab at @scilifelab, @Stockholm_Uni as our guest this week. What a great knowledge and boost for us of the In Situ Sequencing (ISS) methodology:)
May is Brain Tumour Awareness Month. Help us #TurnMayGrey! Look out for our #BrainTumourAwarenessMonth posts on the 1st of May and learn more about how you can help raise awareness for brain tumours.
Thanks to the organising teams from Labena Slovenia and @10xGenomics for their invitation to speak at the Single Cell & Spatial Discovery Symposium in Ljubljana. Indeed an amazing event. Why do we do it? "To catch and see the plasticity of cancer in time and space" @cut_cancer
The EACR Congress is coming to the Netherlands in June!
Join the wider cancer research community in Rotterdam for four days of fantastic science and networking opportunities at #EACR2024 🤝
Early rate registration deadline: 29 April
➡️ https://t.co/dYUl2wD7aL